Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1986 2
1994 1
1995 1
1996 8
1997 4
1998 5
1999 1
2000 5
2001 2
2002 1
2008 1
2018 2
2019 3
2020 3
2021 3
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of renal outcomes between sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists.
Kobayashi K, Toyoda M, Hatori N, Sakai H, Furuki T, Chin K, Kimura M, Saito N, Kanaoka T, Aoyama T, Umezono T, Ito S, Suzuki D, Takeda H, Minagawa F, Degawa H, Machimura H, Hishiki T, Umezawa S, Shimura H, Nakajima S, Yamamoto H, Sato K, Miyakawa M, Terauchi Y, Tamura K, Kanamori A. Kobayashi K, et al. Among authors: degawa h. Diabetes Res Clin Pract. 2022 Mar;185:109231. doi: 10.1016/j.diabres.2022.109231. Epub 2022 Feb 5. Diabetes Res Clin Pract. 2022. PMID: 35131376
Kidney transplantation from spousal donors.
Kikuchi K, Narumi Y, Hama K, Iwamoto H, Uchiyama M, Kozaki K, Degawa H, Matsuno N, Kozaki M, Nagao T. Kikuchi K, et al. Among authors: degawa h. Transplant Proc. 2000 Nov;32(7):1817-8. doi: 10.1016/s0041-1345(00)01359-2. Transplant Proc. 2000. PMID: 11119951 No abstract available.
Heterogeneity assessment of vaccine-induced effects using point-of-care surrogate neutralization test for severe acute respiratory syndrome coronavirus 2.
Watanabe Y, Matsuba I, Watanabe K, Kunishima T, Takechi Y, Takuma T, Araki Y, Hirotsu N, Sakai H, Oikawa R, Danno H, Fukuda M, Futagami S, Wada K, Yamamoto H, Itoh F, Oda I, Hatori Y, Degawa H. Watanabe Y, et al. Among authors: degawa h. J Clin Lab Anal. 2022 Jul;36(7):e24545. doi: 10.1002/jcla.24545. Epub 2022 Jun 9. J Clin Lab Anal. 2022. PMID: 35678628 Free PMC article.
The Proportion of Long-term Response to Anti-N IgG Antibody after 12 Months for COVID-19 Subclinical Infections and a Longitudinal Survey for COVID-19 Subclinical Infections in 2021.
Matsuba I, Takuma T, Hatori N, Takai M, Watanabe Y, Takada N, Kishi S, Matsuzawa Y, Nishikawa T, Kunishima T, Degawa H, Nishikawa M, Ono Y, Miyakawa M, Hatori Y, Kanamori A. Matsuba I, et al. Among authors: degawa h. Intern Med. 2022 Oct 15;61(20):3053-3062. doi: 10.2169/internalmedicine.9628-22. Epub 2022 Aug 10. Intern Med. 2022. PMID: 35945024 Free PMC article.
Study on Continuation of Antibody Prevalence Six Months after Detection of Subclinical Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
Matsuba I, Takuma T, Hatori N, Takai M, Watanabe Y, Takada N, Kishi S, Matsuzawa Y, Nishikawa T, Kunishima T, Degawa H, Nishikawa M, Ono Y, Kanamori A. Matsuba I, et al. Among authors: degawa h. Intern Med. 2022 Jan 15;61(2):159-165. doi: 10.2169/internalmedicine.8019-21. Epub 2021 Nov 6. Intern Med. 2022. PMID: 34744105 Free PMC article.
Time-series transcriptome analysis of peripheral blood mononuclear cells obtained from individuals who received the SARS-CoV-2 mRNA vaccine.
Watanabe Y, Yamamoto H, Matsuba I, Watanabe K, Kunishima T, Takechi Y, Takuma T, Araki Y, Hirotsu N, Sakai H, Oikawa R, Danno H, Fukuda M, Sugino R, Futagami S, Wada K, Itoh F, Tateishi K, Oda I, Hatori Y, Degawa H. Watanabe Y, et al. Among authors: degawa h. J Med Virol. 2023 Jun;95(6):e28884. doi: 10.1002/jmv.28884. J Med Virol. 2023. PMID: 37342886
Survey of the current status of subclinical coronavirus disease 2019 (COVID-19).
Matsuba I, Hatori N, Koido N, Watanabe Y, Ebara F, Matsuzawa Y, Nishikawa T, Kunishima T, Degawa H, Nishikawa M, Ono Y, Kanamori A. Matsuba I, et al. Among authors: degawa h. J Infect Chemother. 2020 Dec;26(12):1294-1300. doi: 10.1016/j.jiac.2020.09.005. Epub 2020 Sep 6. J Infect Chemother. 2020. PMID: 32958395 Free PMC article.
Blood pressure after treatment with sodium-glucose cotransporter 2 inhibitors influences renal composite outcome: Analysis using propensity score-matched models.
Kobayashi K, Toyoda M, Hatori N, Furuki T, Sakai H, Umezono T, Ito S, Suzuki D, Takeda H, Minagawa F, Degawa H, Yamamoto H, Machimura H, Chin K, Hishiki T, Takihata M, Aoyama K, Umezawa S, Minamisawa K, Aoyama T, Hamada Y, Suzuki Y, Hayashi M, Hatori Y, Sato K, Miyakawa M, Tamura K, Kanamori A. Kobayashi K, et al. Among authors: degawa h. J Diabetes Investig. 2021 Jan;12(1):74-81. doi: 10.1111/jdi.13318. Epub 2020 Jul 10. J Diabetes Investig. 2021. PMID: 32506833 Free PMC article.
The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonists.
Kobayashi K, Toyoda M, Hatori N, Tsukamoto S, Kimura M, Sakai H, Furuki T, Chin K, Kanaoka T, Aoyama T, Umezono T, Ito S, Suzuki D, Takeda H, Degawa H, Hishiki T, Shimura H, Nakajima S, Miyauchi M, Yamamoto H, Hatori Y, Hayashi M, Sato K, Miyakawa M, Terauchi Y, Tamura K, Kanamori A. Kobayashi K, et al. Among authors: degawa h. Cardiovasc Endocrinol Metab. 2023 Sep 28;12(4):e0292. doi: 10.1097/XCE.0000000000000292. eCollection 2023 Dec. Cardiovasc Endocrinol Metab. 2023. PMID: 37779602 Free PMC article.
47 results